MDRX logo

Allscripts Healthcare Solutions (MDRX) Stock

Profile

Sector:

Healthcare

Country:

United States

IPO:

26 July 1999

Indexes:

Not included

Description:

Allscripts Healthcare Solutions, Inc. is an information technology company specializing in software and products for healthcare facilities. It has been in operation since 1986 and is registered in the state of Delaware. The company offers software to medical organizations that helps optimize operations, improve efficiency, and enhance customer service quality. Its products are designed for organizations of all sizes, from small medical practices and pharmacies to large healthcare institutions and government health departments. The software covers all aspects of organizational activities.

Events Calendar

Earnings

Next earnings date:

Jan 10, 2025

Recent quarterly earnings:

Mar 01, 2023

Recent annual earnings:

Mar 01, 2023
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Oct 07, 2008
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

28 May '24 TD Cowen
Buy
19 Mar '24 Deutsche Bank
Hold
19 Jan '24 RBC Capital
Outperform
03 Jan '24 Barclays
Equal-Weight
14 Nov '23 Stephens & Co.
Equal-Weight
10 Oct '23 Stephens & Co.
Equal-Weight
06 July '23 Argus Research
Hold
12 Apr '23 Stephens & Co.
Equal-Weight
01 Feb '23 Piper Sandler
Neutral
07 Dec '22 Argus Research
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Glancy Prongay & Murray LLP Announces Investigation of Veradigm Inc. (MDRX)
Glancy Prongay & Murray LLP Announces Investigation of Veradigm Inc. (MDRX)
Glancy Prongay & Murray LLP Announces Investigation of Veradigm Inc. (MDRX)
MDRX
businesswire.com09 December 2024

NEW YORK--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) announces its investigation of Veradigm Inc. (OTCMKTS: MDRX) concerning the Company and its directors' and officers' possible violations of state laws. If you own Veradigm stock, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Tom Kennedy, of GPM, 230 Park Avenue, Suite 358, New York, NY 10169 at tkennedy@gla.

Veradigm Advancing Point of Care Engagement Through Payer-Provider Collaboration
Veradigm Advancing Point of Care Engagement Through Payer-Provider Collaboration
Veradigm Advancing Point of Care Engagement Through Payer-Provider Collaboration
MDRX
businesswire.com19 November 2024

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, today announced an enhanced strategic collaboration with Insiteflow, an electronic health record (EHR) decision workflow platform. This effort expands Veradigm Payer Insights (VPI) beyond the Veradigm EHR footprint into additional EHRs technologies. Together, Veradigm and Insiteflow are placing actionable insights on behalf of Payers at the point of care across multiple EHR platf.

Veradigm Named as the Top Vendor for End-to-End Revenue Cycle Management Solutions
Veradigm Named as the Top Vendor for End-to-End Revenue Cycle Management Solutions
Veradigm Named as the Top Vendor for End-to-End Revenue Cycle Management Solutions
MDRX
businesswire.com29 August 2024

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that Black Book™, a healthcare-centric market research and public opinion research and consulting company, rated Veradigm Payerpath the overall number one vendor for end-to-end revenue cycle management (RCM) solutions for physician practice software and services. “At Veradigm, we are dedicated to seamlessly connecting providers with patients and payers. Veradigm P.

The Portnoy Law Firm Announces Investigation of Veradigm Inc. (OTCMKTS: MDRX)
The Portnoy Law Firm Announces Investigation of Veradigm Inc. (OTCMKTS: MDRX)
The Portnoy Law Firm Announces Investigation of Veradigm Inc. (OTCMKTS: MDRX)
MDRX
globenewswire.com10 June 2024

Investors can contact the law firm at no cost to learn more about recovering their losses.

Robbins LLP Reminds MDRX Stockholders it is Investigating the Officers and Directors of Veradigm Inc. to Determine if They Breached Fiduciary Duties Owed to Shareholders
Robbins LLP Reminds MDRX Stockholders it is Investigating the Officers and Directors of Veradigm Inc. to Determine if They Breached Fiduciary Duties Owed to Shareholders
Robbins LLP Reminds MDRX Stockholders it is Investigating the Officers and Directors of Veradigm Inc. to Determine if They Breached Fiduciary Duties Owed to Shareholders
MDRX
businesswire.com07 June 2024

SAN DIEGO--(BUSINESS WIRE)---- $MDRX #IPO--Robbins LLP is Investigating Allegations Veradigm Inc. (MDRX) Violated Securities Laws in Connection with Misstatements in Financial Reporting.

Robbins LLP Informs Investors it is Investigating the Officers and Directors of Veradigm Inc. (MDRX) for Breaches of Fiduciary Duty
Robbins LLP Informs Investors it is Investigating the Officers and Directors of Veradigm Inc. (MDRX) for Breaches of Fiduciary Duty
Robbins LLP Informs Investors it is Investigating the Officers and Directors of Veradigm Inc. (MDRX) for Breaches of Fiduciary Duty
MDRX
globenewswire.com03 June 2024

SAN DIEGO, June 03, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP is investigating Veradigm Inc. (OTC: MDRX) to determine whether certain Veradigm officers and directors violated securities laws and breached fiduciary duties to shareholders in connection with misstatements in the Company's financial reporting. Veradigm is a healthcare technology company that provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally.

Veradigm Payerpath Rated Highest in Client Satisfaction
Veradigm Payerpath Rated Highest in Client Satisfaction
Veradigm Payerpath Rated Highest in Client Satisfaction
MDRX
businesswire.com30 May 2024

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that Black Book Research, a healthcare-centric market research and public opinion research and consulting company, rated Veradigm Payerpath the overall number one provider of claims and clearinghouse platform solutions for small medical practices. Veradigm Payerpath achieved top scores in 11 of 18 clearinghouse-focused key performance indicators for solo and indep.

Veradigm to Explore Strategic Alternatives and Reaffirms 2024 Guidance
Veradigm to Explore Strategic Alternatives and Reaffirms 2024 Guidance
Veradigm to Explore Strategic Alternatives and Reaffirms 2024 Guidance
MDRX
businesswire.com28 May 2024

CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm Inc. (OTCMKTS: MDRX, the "Company”), a leading provider of healthcare data and technology solutions, today announced that it has initiated a process to explore strategic alternatives to maximize shareholder value. As part of the evaluation process, Veradigm will explore potential strategic alternatives that may include, but are not limited to, a sale, merger, strategic business combination or other transaction. The Company cannot assure that its exploration wi.

Veradigm (MDRX) to Acquire AI Service Provider ScienceIO
Veradigm (MDRX) to Acquire AI Service Provider ScienceIO
Veradigm (MDRX) to Acquire AI Service Provider ScienceIO
MDRX
Zacks Investment Research01 March 2024

Veradigm (MDRX) is set to acquire ScienceIO to benefit its Provider, Payer and Life Sciences businesses, offering highly differentiated and advanced products to its customers.

Veradigm's (MDRX) Acquires Koha Health to Solidify Market Presence
Veradigm's (MDRX) Acquires Koha Health to Solidify Market Presence
Veradigm's (MDRX) Acquires Koha Health to Solidify Market Presence
MDRX
Zacks Investment Research05 January 2024

Veradigm's (MDRX) acquisition of Koha Health will likely enhance its ability to deliver efficient revenue cycle services by incorporating Musculoskeletal Medicine specialty subject matter expertise.

  • 1(current)
  • 2
  • 1(current)
  • 2

FAQ

  • What is the primary business of Allscripts Healthcare Solutions?
  • What is the ticker symbol for Allscripts Healthcare Solutions?
  • Does Allscripts Healthcare Solutions pay dividends?
  • What sector is Allscripts Healthcare Solutions in?
  • What industry is Allscripts Healthcare Solutions in?
  • What country is Allscripts Healthcare Solutions based in?
  • When did Allscripts Healthcare Solutions go public?
  • Is Allscripts Healthcare Solutions in the S&P 500?
  • Is Allscripts Healthcare Solutions in the NASDAQ 100?
  • Is Allscripts Healthcare Solutions in the Dow Jones?
  • When was Allscripts Healthcare Solutions's last earnings report?
  • When does Allscripts Healthcare Solutions report earnings?
  • Should I buy Allscripts Healthcare Solutions stock now?

What is the primary business of Allscripts Healthcare Solutions?

Allscripts Healthcare Solutions, Inc. is an information technology company specializing in software and products for healthcare facilities. It has been in operation since 1986 and is registered in the state of Delaware. The company offers software to medical organizations that helps optimize operations, improve efficiency, and enhance customer service quality. Its products are designed for organizations of all sizes, from small medical practices and pharmacies to large healthcare institutions and government health departments. The software covers all aspects of organizational activities.

What is the ticker symbol for Allscripts Healthcare Solutions?

The ticker symbol for Allscripts Healthcare Solutions is NASDAQ:MDRX

Does Allscripts Healthcare Solutions pay dividends?

No, Allscripts Healthcare Solutions does not pay dividends

What sector is Allscripts Healthcare Solutions in?

Allscripts Healthcare Solutions is in the Healthcare sector

What industry is Allscripts Healthcare Solutions in?

Allscripts Healthcare Solutions is in the Health Information Services industry

What country is Allscripts Healthcare Solutions based in?

Allscripts Healthcare Solutions is headquartered in United States

When did Allscripts Healthcare Solutions go public?

Allscripts Healthcare Solutions's initial public offering (IPO) was on 26 July 1999

Is Allscripts Healthcare Solutions in the S&P 500?

No, Allscripts Healthcare Solutions is not included in the S&P 500 index

Is Allscripts Healthcare Solutions in the NASDAQ 100?

No, Allscripts Healthcare Solutions is not included in the NASDAQ 100 index

Is Allscripts Healthcare Solutions in the Dow Jones?

No, Allscripts Healthcare Solutions is not included in the Dow Jones index

When was Allscripts Healthcare Solutions's last earnings report?

Allscripts Healthcare Solutions's most recent earnings report was on 1 March 2023

When does Allscripts Healthcare Solutions report earnings?

The next expected earnings date for Allscripts Healthcare Solutions is 10 January 2025

Should I buy Allscripts Healthcare Solutions stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions